A network meta‐analysis for the comparison of efficacy and safety of interleukin (IL)‐23 targeted drugs in the treatment of moderate to severe psoriasis
J Shi, J Xu, Y Chen - Dermatologic Therapy, 2020 - Wiley Online Library
A variety of interleukin‐23 targeted drugs have been used to treat moderate to severe
psoriasis, but it is not clear which is most effective. This network meta‐analysis compared …
psoriasis, but it is not clear which is most effective. This network meta‐analysis compared …
A network meta‐analysis for the comparison of efficacy and safety of interleukin (IL)‐23 targeted drugs in the treatment of moderate to severe psoriasis.
J Shi, J Xu, Y Chen - Dermatologic Therapy, 2020 - search.ebscohost.com
A variety of interleukin‐23 targeted drugs have been used to treat moderate to severe
psoriasis, but it is not clear which is most effective. This network meta‐analysis compared …
psoriasis, but it is not clear which is most effective. This network meta‐analysis compared …
A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis.
J Shi, J Xu, Y Chen - Dermatologic Therapy, 2020 - europepmc.org
A variety of interleukin-23 targeted drugs have been used to treat moderate to severe
psoriasis, but it is not clear which is most effective. This network meta-analysis compared …
psoriasis, but it is not clear which is most effective. This network meta-analysis compared …
A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis
J Shi, J Xu, Y Chen - Dermatologic therapy, 2020 - pubmed.ncbi.nlm.nih.gov
A variety of interleukin-23 targeted drugs have been used to treat moderate to severe
psoriasis, but it is not clear which is most effective. This network meta-analysis compared …
psoriasis, but it is not clear which is most effective. This network meta-analysis compared …